CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $132,000 | -37.1% | 2,500 | -19.4% | 0.00% | 0.0% |
Q4 2017 | $210,000 | -50.9% | 3,100 | -40.4% | 0.00% | -50.0% |
Q3 2017 | $428,000 | -18.3% | 5,200 | -7.1% | 0.00% | 0.0% |
Q2 2017 | $524,000 | -41.5% | 5,600 | -60.2% | 0.00% | -50.0% |
Q1 2017 | $896,000 | +7.8% | 14,079 | +55.8% | 0.00% | 0.0% |
Q3 2015 | $831,000 | -26.0% | 9,039 | -29.3% | 0.00% | -20.0% |
Q2 2015 | $1,123,000 | +15.8% | 12,779 | -8.7% | 0.01% | +25.0% |
Q1 2014 | $970,000 | +14.9% | 14,000 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $844,000 | +21.8% | 14,000 | +22.8% | 0.00% | +33.3% |
Q3 2013 | $693,000 | -54.8% | 11,400 | -50.2% | 0.00% | -57.1% |
Q2 2013 | $1,532,000 | – | 22,879 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |